Home › Targets › IL-13Rα2

IL-13Rα2 (2 companies · 4 programs)

Companies with an active program directed at IL-13Rα2.

Medicenna Therapeutics Corp. MDNAF

MDNA11 — Solid Tumors Phase 1
MDNA132 Preclinical
MDNA213 Preclinical

Fortress Biotech, Inc. FBIO

MB-109